Efficacy of Nucleo CMP Forte in Traumatic Brain Injury in Pediatrics

Last updated: August 1, 2020
Sponsor: Sherief Abd-Elsalam
Overall Status: Active - Recruiting

Phase

3

Condition

Neurologic Disorders

Treatment

N/A

Clinical Study ID

NCT04499755
KFS protocol
  • Ages < 18
  • All Genders

Study Summary

Efficacy of Nucleo CMP Forte in Traumatic Brain Injury in Pediatrics

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Children with traumatic brain injury: Moderate and Severe.

Exclusion

Exclusion Criteria:

  • Underlying CNS disorders,

Study Design

Total Participants: 100
Study Start date:
June 01, 2020
Estimated Completion Date:
December 10, 2030

Study Description

The study aims to study the Efficacy of Nucleo CMP Forte in Traumatic Brain Injury in Pediatrics

Connect with a study center

  • Sherief Abd-Elsalam

    Tanta,
    Egypt

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.